J&J Tries, Fails to Squeeze Whistle Blower in Texas Risperdal Case

1
88

In giving final approval to the $158 million settlement with Texas over illegal promotion of Risperdal, Judge John Dietz denied Johnson &Johnson’s request to halve whistleblower Allen Jones’ share of the award.  Jones, who lost his job as an investigator for Pennsylvania’s Office of the Inspector General when he brought attention to Medicaid fraud which has resulted in dozens of resolved and pending lawsuits, worried that J&J’s effort to limit his award would discourage other whistleblowers and law firms from filing such cases. “The number is not what it was originally about,” Jones said.

Article →
Related articles:
Bloomberg News
Austin Statesman

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleArkansas Alleges Risperdal Causes Deaths in the Elderly and Lactation in Young Boys
Next articleFDA Adds Warnings to Celexa’s Label
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

1 COMMENT

LEAVE A REPLY